Intermountain was cited as saying that the new programme establishes the organisation as one of the first in the US to offer cancer treatment by using genetic sequencing.
Intermountain's cancer genomics unit will be headed by Dr Lincoln Nadauld. Dr Nadauld commented that the new approach offers less side effects and additional treatment options for advanced cancers.
Perrigo to acquire United States rights for Entocort from AstraZeneca
US FDA approves Boehringer Ingelheim's Pradaxa
Phase II clinical trial for potential treatment of androgenetic alopecia completed by Samumed
Life Sciences Partners collaborates on immuno-oncology with Bristol-Myers Squibb
Arsanis initiates first cohort in Phase one clinical trial of ASN100
Impax introduces generic Avodart (Dutasteride) Capsules, 0.5 mg
Mylan unveils generic FazaClo orally disintegrating tablets for treating schizophrenia